CASE REPORT A case of long QT syndrome: challenges on a bumpy road Peter Magnusson1,2 & Per-Erik Gustafsson2 1Cardiology Research Unit, Department of Medicine, Karolinska Institutet, Stockholm SE-171 76, Sweden 2Centre for Research and Development, Uppsala University/Region Gavleborg,€ Gavle€ SE-801 87, Sweden Correspondence Key Clinical Message Peter Magnusson, Cardiology Research Unit, Department of Medicine, Karolinska Beta-agonist treatment during pregnancy may unmask the diagnosis of long QT Institutet, Karolinska University Hospital/ syndrome. The QT prolongation can result in functional AV block. A history of Solna, SE-171 76 Stockholm, Sweden. Tel: seizure and/or sudden death in a family member should raise suspicion of ven- +46(0)705 089407; Fax: +46(0)26 154255; tricular tachycardia. More than one mutation may coexist. Refusal of beta- E-mail:
[email protected] blocker therapy complicates risk stratification. Funding Information Keywords No sources of funding were declared for this Genetic, implantable cardioverter–defibrillator, long QT syndrome, pregnancy, study. premature ventricular complex, risk stratification, sudden cardiac death. Received: 16 December 2016; Revised: 29 March 2017; Accepted: 4 April 2017 Clinical Case Reports 2017; 5(6): 954–960 doi: 10.1002/ccr3.985 Introduction experienced palpitations, and her ECG was abnormal, revealing PVCs, atrioventricular (AV) 2:1 block and QT Long QT syndrome (LQTS) is linked to mutations in the prolongation (520 msec) in precordial lead V5 during ion channels, which can lead to disturbances in ventricu- sinus rhythm at 90 beats per minute (Fig. 1) and rhythm lar repolarization [1]. This condition puts patients at risk strip while walking (Fig.